Risk of Confirmed Guillain-Barre Syndrome Following Receipt of Monovalent Inactivated Influenza A (H1N1) and Seasonal Influenza Vaccines in the Vaccine Safety Datalink Project, 2009-2010
Sharon K. Greene(Boston Children's Hospital), Grace M. Lee, Matthew F. Daley(Kaiser Permanente), Claudia Vellozzi(Centers for Disease Control and Prevention), Steven J. Jacobsen(Mayo Clinic), Bruce Fireman(Kaiser Permanente), Edward A. Belongia(Marshfield Clinic), Eric Weintraub, Tracy A. Lieu(Harvard University), Lingling Li(Guizhou Academy of Agricultural Sciences), Ruihua Yin(Qingdao University), Anthony A. Amato(Brigham and Women's Hospital), Sarah Sheikh(Biogen (United States)), Roger Baxter(Unknown), Martin Kulldorff(Harvard Pilgrim Health Care), Doreen Ho(Harvard University), Melisa D. Rett(Beth Israel Deaconess Medical Center)
Cited by 90
Related Papers
Antigenic and Genetic Characteristics of Swine-Origin 2009 A(H1N1) Influenza Viruses Circulating in Humans
|Science|2009|2.5k
Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis
|The Lancet Infectious Diseases|2011|1.8k
Effects of the COVID-19 Pandemic on Routine Pediatric Vaccine Ordering and Administration — United States, 2020
|MMWR Morbidity and Mortality Weekly Report|2020|720
Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices — United States, June 2021
|MMWR Morbidity and Mortality Weekly Report|2021|602